top of page
Search


Malaysia: MDA Strengthens Engagement with Industry on Innovation & Regulatory Pathways
On 22 September 2025 , the Medical Device Authority (MDA) led a key stakeholder engagement session with the Association of Malaysian Medical Industries (AMMI) in Penang , held at the Iconic Marjorie Hotel. The session, attended by 51 industry participants, focused on strategic discussions regarding regulatory sandboxes for high-tech medical devices, particularly AI-enabled medical devices, and the Medical Device Single Audit Program (MDSAP). These focus areas reflect MDA’s

ARQon
7 days ago2 min read


Malaysia’s Medical Device Registration: A fresh look at MDA’s Verification Route
In the ever-evolving world of medical device regulation, staying ahead of the curve is crucial, especially when entering rapidly growing markets like Malaysia. The newly released Second Edition of MDA/GD/0070 from Malaysia’s Medical Device Authority (MDA) brings clarity and structure to the registration process, especially for manufacturers and authorised representatives who opt for conformity assessment by way of the verification route. Here’s what you need to know and how t

ARQon
Nov 102 min read


Malaysia Reinforces Control on Influenza Test Kits: Professional Use Only
31 October 2025 – Cyberjaya, Malaysia The Medical Device Authority (MDA), under the Ministry of Health (MOH), has issued a media statement to reinforce regulatory control and monitoring of influenza test kits currently available in the Malaysian market. The announcement clarifies that all influenza test kits are classified as In Vitro Diagnostic (IVD) Medical Devices intended strictly for use by trained healthcare professionals. This means these test kits are not approved for

ARQon
Nov 82 min read


MDA Opens Public Comment on Guidance for Orphaned Medical Devices
The Medical Device Authority (MDA) of Malaysia has released the first edition draft guidance document titled “𝘈𝘱𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘧𝘰𝘳 𝘊𝘰𝘯𝘧𝘪𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘚𝘵𝘢𝘵𝘶𝘴 𝘰𝘧 𝘖𝘳𝘱𝘩𝘢𝘯𝘦𝘥 𝘔𝘦𝘥𝘪𝘤𝘢𝘭 𝘋𝘦𝘷𝘪𝘤𝘦”. It is inviting industry stakeholders to provide feedback. This document is a significant step toward managing legacy medical devices that remain in healthcare facilities without active manufacturer or Authorised Representative (AR) oversight, ensur

ARQon
Oct 212 min read


Malaysia’s Regulatory Modernization with MDSAP and Streamlined Guidance
In a powerful display of commitment to global harmonization and regulatory efficiency, Malaysia’s Medical Device Authority (MDA) has...

ARQon
Oct 22 min read


NPRA Alerts on Lamotrigine Safety Risk
On 17 September 2025 , the National Pharmaceutical Regulatory Agency (NPRA) released a safety signal alert concerning the anticonvulsant...

ARQon
Sep 182 min read


Malaysia: MDA, HSA, Forge Closer Ties with pilot Medical Device Regulatory Reliance Programme (1 Sept 2025 - 28 Feb 2026)
22 August 2025 marked a milestone moment for the medical device industry in Southeast Asia, as the Medical Device Authority (MDA) and the...

ARQon
Aug 252 min read


Malaysia: Malaysia-China Medical Device Regulatory Reliance Programme Launches Pilot Phase 1 (30 July 2025 - 30 September 2025)
In a landmark move for international medical device regulation, the Medical Device Authority (MDA) and National Medical Products...

ARQon
Aug 42 min read


Malaysia: Mandatory Screening Package for New Drug and Biologic Registrations (effective from 16 June 2025
In a continued effort to strengthen the quality and efficiency of regulatory assessments, the National Pharmaceutical Regulatory Agency...

ARQon
Jul 302 min read


Malaysia: Globally Leads with New Medical Device Regulatory Reliance Programme (effective from 30 July 2025)
In a world where healthcare innovation often outpaces regulations, one country is stepping forward to bridge that gap with confidence,...

ARQon
Jul 252 min read


Malaysia: MDA Bans Online Sales of Optical Devices and Contact Lenses
The Medical Device Authority (MDA) has released an official statement reinforcing a strict prohibition on the online sale of optical...

ARQon
Jun 182 min read


Malaysia: MDA Issues Advisory on Malaria Test Kit
The World Health Organization (WHO) released a notification regarding the performance of certain malaria diagnostic test kits , which has...

ARQon
May 271 min read


Malaysia: MDA Implements Medical Device Import Permit Requirement (transition w.e.f 14 April 2025)
In a move to enhance the regulation and traceability of medical device imports, the Medical Device Authority (MDA) has officially...

ARQon
May 52 min read


Malaysia: MDA Sets 2-Year Validity Period for Product Classification Letters (w.e.f 1 May 2025)
The Medical Device Authority (MDA) has announced a key regulatory update that impacts all stakeholders within the medical device and...

ARQon
Apr 171 min read


Malaysia: Transition to Online Product Classification Application Process by MDA (w.e.f. 1 May 2025)
Starting 1 May 2025 , the Medical Device Authority (MDA) is pleased to announce that all product classification applications must be...

ARQon
Apr 141 min read


Malaysia: MDA Releases First Edition Guidance on Importation of Medical Device for Re-Export (IRE)
To provide clarity and streamline compliance with the Medical Device Act 2012 (Act 737), on the 13 March 2025, the Medical Device...

ARQon
Mar 192 min read


Malaysia: Online Advertisement Applications Begin March 2025
The Medical Device Authority (MDA) is set to enhance its application process by transitioning to a fully online system for advertisement...

ARQon
Feb 61 min read


Malaysia: NPRA’s New Protocol Assessment and Testing Procedure for Registered Vaccine Products
The National Pharmaceutical Regulatory Agency (NPRA) is set to introduce key initiative aimed at strengthening the quality monitoring of...

ARQon
Jan 132 min read


Malaysia: NPRA's Transition to Remote GDP Inspections (w.e.f. 18 December 2024)
The National Pharmaceutical Regulatory Agency (NPRA) has introduced a progressive initiative to improve the regulatory process for...

ARQon
Dec 26, 20242 min read


Malaysia: NPRA Bans Chloroform and Chloroform Spirit as Preservatives (w.e.f. 19 November 2024)
Effective 19 November 2024 , the National Pharmaceutical Regulatory Agency (NPRA) has issued Directive No. 16/2024, announcing the...

ARQon
Nov 27, 20242 min read
bottom of page
.png)